Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The Ortho Evra birth control patch has updated the CONTRAINDICTATIONS, WARNINGS and ADVERSE REACTIONS sections on its label and packaging, according to the Food and Drug Administration’s MedWatch July 2009 Drug Safety Labeling Changes posting. Ortho Evra was one of 38 drugs listed in the report.

Read the rest of this entry »

Students at Texas Christian University (TCU) now have access to more affordable contraceptives through the university’s Health Center, according to the TCU news Web site Daily Skiff. The Health Center negotiated a contract with drug companies to offer the discounted rates to students requesting contraceptives such as Ortho Tri-Cyclen and the Ortho Evra Contraceptive Transdermal Patch.

Read the rest of this entry »

The FDA approved a label change to Johnson & Johnson’s Ortho Evra birth control patch on January 18, 2008. The patch has been known to cause blood clots which can lead to pulmonary embolism and death. The label change comes after testing revealed women on the patch between the ages of 15-44 are at a higher risk for pulmonary embolism.

Read the rest of this entry »

Johnson & Johnson agreed to pay $1.25 million to settle a lawsuit over the death of a 14-year-old girl who used the company’s Ortho Evra birth-control patch, according to court records.

Read the rest of this entry »